Kapitalisasi marang bathi Qilian International Corp (QLI)

This P/E ratio chart, which currently stands at -24.70, clearly illustrates price changes and allows for a valuation of Qilian International (QLI). Qilian International (QLI) produces chemical extracts and traditional medicines, leveraging state-issued GMP licenses. However, strict PRC oversight and raw material price volatility create financial risks. Furthermore, the firm is fighting for market share in a low-margin segment, trailing behind large state-owned enterprises.

The efficiency of Qilian International (QLI) depends directly on PRC government regulation and raw material costs. The ratio of market capitalization to net income, reflected through the company's adjusted P/E, measures the investment payback period. The stability of this trend often masks the internal restructuring of institutional portfolios. Analyzing this momentum during the consolidation phase foreshadows a future price reversal. The final valuation of the asset requires accounting for export demand.